GILEAD SCIENCES, INC. (GILD)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 7, 2026

Verified against EDGAR
Total Assets
$49.36B
Stockholders' Equity
$11.83B
Cash & Equivalents
$3.18B
Long-Term Debt
$26.25B

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, GILEAD SCIENCES, INC. reported revenue of $7.80B, net income of -$10.50B, and total assets of $49.36B. Every figure below is taken directly from GILEAD SCIENCES, INC.'s SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2016–FY2025 · as reported

$30.39B$15.26B$123.0M
FY2016FY2019FY2022FY2025
Revenue$29.44BNet income$8.51B
FY2016 revenue
$30.39B
FY2025 revenue
$29.44B

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$29.44B$8.51B
FY2024$28.75B$480.0M
FY2023$27.12B$5.67B
FY2022$27.28B$4.59B
FY2021$27.30B$6.22B
FY2020$24.69B$123.0M
FY2019$22.45B$5.39B
FY2018$22.13B$5.46B
FY2017$26.11B$4.63B
FY2016$30.39B$13.50B

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KOct 29, 2026on EDGAR ↗
10-QAug 6, 2026on EDGAR ↗
8-KAug 4, 2026on EDGAR ↗
13F-HRAug 3, 2026on EDGAR ↗
8-KMay 20, 2026on EDGAR ↗
13F-HRMay 8, 2026on EDGAR ↗
10-QMay 7, 2026on EDGAR ↗
8-KMay 7, 2026on EDGAR ↗
8-KMay 4, 2026on EDGAR ↗
8-KApr 28, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$49.36Bsource ↗
Stockholders’ Equity$11.83Bsource ↗
Cash & Equivalents$3.18Bsource ↗
Long-Term Debt$26.25Bsource ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue$7.80Bsource ↗
Net Income-$10.50Bsource ↗
Operating Income-$10.39Bsource ↗
Gross Profit$6.22Bsource ↗
Cost of Revenue$1.58Bsource ↗
R&D Expense$1.76Bsource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$-8.45source ↗
EPS (basic)$-8.45source ↗
Shares Outstanding1.24Bsource ↗
Cash from Operations$3.57Bsource ↗
Cash from Financing$2.34Bsource ↗
Cash from Investing-$10.35Bsource ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
0
Sells
42
Net shares
-184.0K

Restatement history

Point-in-time

12 of 601 annual fact-keys were materially restated between filings: what GILEAD SCIENCES, INC. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.

See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.

Deeper fundamentals

A free API key reaches GILD’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/GILD

MCP tool: get_sec_fundamentals ticker=GILD

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/GILD/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=GILD as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/GILD/history

MCP tool: get_fundamentals_history ticker=GILD

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/GILD

MCP tool: get_financial_health ticker=GILD

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.